文献速递肺栓塞与肺血管病

急性肺栓塞循证风险分层:ISTH SSC 血栓性疾病预测与诊断变量小组委员会意见书

Evidence-based risk stratification of patients with acute pulmonary embolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease
RSS 订阅 · 指南共识 · 肺栓塞 · 2025-12-07

国际血栓与止血学会(ISTH)多学科工作组对随机对照试验和前瞻性管理研究进行文献综述,聚焦急性肺栓塞住院、入住 ICU、再灌注治疗和出院四项管理决策。结论认为 Hestia 标准或(简化)肺栓塞严重指数结合临床判断可用于筛选门诊治疗患者,血流动力学不稳定仍是目前唯一确立的再灌注指征,ICU 入住缺乏肺栓塞特异性证据,证据缺口显著。

要点

  • Hestia 标准或(简化)肺栓塞严重指数结合临床判断可用于筛选门诊治疗患者。
  • 血流动力学不稳定是目前唯一确立的再灌注治疗指征,稳定患者不推荐常规再灌注。
  • ICU 入住决策缺乏肺栓塞特异性证据,出院可借助(简化)肺栓塞严重指数结合稳定性评估。

核心结论

  • 现有证据支持用 Hestia 标准或(简化)肺栓塞严重指数结合临床判断筛选适合门诊治疗的肺栓塞患者。
  • 血流动力学不稳定仍是目前唯一确立的再灌注治疗指征,高质量证据不支持对血流动力学稳定患者常规再灌注。
  • 入住 ICU 缺乏肺栓塞特异性证据,出院决策可借助(简化)肺栓塞严重指数结合临床稳定性评估。
  • 总体证据缺口显著,需进一步研究以指导临床实践和未来指南。

研究设计与样本

  • 国际血栓与止血学会(ISTH)组建多学科国际专家工作组开展文献综述。
  • 检索随机对照试验和前瞻性管理研究,要求报告硬性临床结局且偏倚风险评估为低。
  • 综述聚焦住院、入住 ICU、再灌注治疗和出院四项管理决策。

主要发现

  • 支持用 Hestia 标准或(简化)肺栓塞严重指数结合临床判断选择门诊治疗患者。
  • 无肺栓塞特异性证据指导 ICU 入住决策。
  • 血流动力学不稳定患者的再灌注治疗仅由 1 项小型随机试验支持。
  • 现有高质量证据不支持对血流动力学稳定患者常规行再灌注治疗。

关键数值与推荐

  • 门诊治疗筛选:Hestia 标准或(简化)肺栓塞严重指数,结合临床判断。
  • 再灌注治疗:血流动力学不稳定为目前唯一确立的指征。
  • 出院决策:(简化)肺栓塞严重指数结合临床稳定性评估。

临床怎么用

  • 对急性肺栓塞患者可用 Hestia 标准或(简化)肺栓塞严重指数结合临床判断评估门诊治疗可行性。
  • 再灌注治疗应限于血流动力学不稳定患者,稳定患者不常规再灌注。
  • 出院前用(简化)肺栓塞严重指数结合临床稳定性评估,ICU 入住决策需个体化。
  • 现有指南在风险分级定义和治疗推荐上存在差异,临床决策需结合本共识证据。

局限性

  • 入住 ICU 缺乏肺栓塞特异性证据。
  • 血流动力学不稳定患者的再灌注仅由 1 项小型随机试验支持。
  • 总体证据缺口显著,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

J Thromb Haemost. 2026 Mar;24(3):1181-1189. doi: 10.1016/j.jtha.2025.10.036. Epub 2025 Dec 5. ABSTRACT BACKGROUND: Acute pulmonary embolism (PE) includes clinical presentations with a wide spectrum of severity, making risk stratification essential to guide the decision-making process in daily practice. However, international guidelines differ in their definition of risk classes and consequent treatment recommendations. OBJECTIVES: To summarize high-quality evidence supporting 4 key management decisions in acute PE: hospitalization, intensive care unit admission, reperfusion therapy, and discharge. METHODS: A multidisciplinary International Society on Thrombosis and Haemostasis task force, composed of international experts, conducted a literature review of randomized controlled trials and prospective management studies reporting hard clinical outcomes and assessed as having a low risk of bias, focusing on any of the 4 management decisions detailed above. RESULTS: Available evidence supports the use of either the Hestia criteria or the (simplified) PE Severity Index, combined with clinical judgment, to select PE patients for outpatient treatment. In contrast, no PE-specific evidence exists to guide intensive care unit admission. Reperfusion therapy in hemodynamically unstable patients is supported by 1 small randomized trial, while currently available high-quality evidence does not support routine reperfusion therapy in hemodynamically stable patients; therefore, hemodynamic instability remains the only established indication for reperfusion therapy to date. The decision to discharge a PE patient may be supported by the use of the (simplified) PE Severity Index, combined with clinical assessment of stability. CONCLUSION: Overall, substantial evidence gaps persist, underscoring the need for further research to inform clinical practice and future guidelines. PMID: 41354154 | DOI: 10.1016/j.jtha.2025.10.036

来源:指南共识 · 肺栓塞,查看原文。版权归原作者所有。

引用

  1. 指南共识 · 肺栓塞:Evidence-based risk stratification of patients with acute pulmonary embolism: communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。